| Date Filed | Type | Description |
| 04/25/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2018 |
4
| Katz Richard D (Vice President and CFO) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Granted 22,629 shares
@ $0 |
|
| 03/30/2018 |
4
| Harrelson Lori R. (Vice President of Finance) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Granted 22,629 shares
@ $0 |
|
| 03/30/2018 |
4
| Nicolette Charles A. (CSO and Vice President of R&D) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Granted 27,150 shares
@ $0 |
|
| 03/30/2018 |
4
| Abbey Jeffrey D (CEO) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Granted 67,887 shares
@ $0 |
|
| 01/12/2018 |
4/A
| Katz Richard D (Vice President and CFO) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Sold 104,435 shares
@ $0.1647, valued at
$17.2k
|
|
| 01/12/2018 |
4/A
| Nicolette Charles A. (CSO and Vice President of R&D) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Sold 100,250 shares
@ $0.1646, valued at
$16.5k
|
|
| 01/12/2018 |
4/A
| Harrelson Lori R. (Vice President of Finance) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Sold 64,329 shares
@ $0.1647, valued at
$10.6k
|
|
| 01/12/2018 |
4/A
| Abbey Jeffrey D (President, CEO) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Sold 124,987 shares
@ $0.1646, valued at
$20.6k
|
|
| 01/12/2018 |
4
| Harrelson Lori R. (Vice President of Finance) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Sold 64,329 shares
@ $0.1647, valued at
$10.6k
|
|
| 01/12/2018 |
4
| Nicolette Charles A. (CSO and Vice President of R&D) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Sold 100,250 shares
@ $0.1646, valued at
$16.5k
|
|
| 01/12/2018 |
4
| Abbey Jeffrey D (President, CEO) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Sold 124,987 shares
@ $0.1646, valued at
$20.6k
|
|
| 01/12/2018 |
4
| Katz Richard D (Vice President and CFO) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Sold 104,435 shares
@ $0.1647, valued at
$17.2k
|
|
| 01/05/2018 |
4
| Abbey Jeffrey D (President, CEO) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Sold 114,702 shares
@ $0.1632, valued at
$18.7k
|
|
| 01/05/2018 |
4
| Katz Richard D (Vice President and CFO) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Sold 101,228 shares
@ $0.1634, valued at
$16.5k
|
|
| 01/05/2018 |
4
| Nicolette Charles A. (CSO and Vice President of R&D) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Sold 92,001 shares
@ $0.1637, valued at
$15.1k
|
|
| 01/05/2018 |
4
| Harrelson Lori R. (Vice President of Finance) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Sold 59,072 shares
@ $0.1635, valued at
$9.7k
|
|
| 01/05/2018 |
4
| Abbey Jeffrey D (President, CEO) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Sold 114,702 shares
@ $0.1632, valued at
$18.7k
|
|
| 11/02/2017 |
4
| Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Disposed of 99,495 shares
@ $795.96, valued at
$79.2M
|
|
| 09/28/2017 |
4
| MORRISON RICHARD G (Director) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Granted 30,000 options to buy
@ $0.17, valued at
$5.1k
|
|
| 09/28/2017 |
3
| MORRISON RICHARD G (Director) has filed a Form 3 on ARGOS THERAPEUTICS INC |
| 08/31/2017 |
4
| Harrelson Lori R. (Vice President of Finance) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Granted 320,683 shares
@ $0 |
|
| 08/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/31/2017 |
4
| Nicolette Charles A. (Chief Science Officer) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Granted 499,445 shares
@ $0 |
|
| 08/31/2017 |
4
| Abbey Jeffrey D (CEO) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Granted 622,685 shares
@ $0 |
|
| 06/23/2017 |
4
| Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Bought options to buy
@ $0.5, valued at
$0 |
|
| 01/23/2017 |
4
| Harrelson Lori R. (Vice President Finance) has filed a Form 4 on ARGOS THERAPEUTICS INC |
| 01/23/2017 |
4
| Winterbottom Joan (Chief Human Resources Officer) has filed a Form 4 on ARGOS THERAPEUTICS INC |
| 01/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/23/2017 |
4
| Abbey Jeffrey D (CEO) has filed a Form 4 on ARGOS THERAPEUTICS INC |
|